Optimizing pharmacotherapy for bipolar alcoholics

Trial Profile

Optimizing pharmacotherapy for bipolar alcoholics

Phase of Trial: Phase I/II

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Naltrexone (Primary) ; Valproate semisodium (Primary)
  • Indications Alcoholism; Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2013 Planned end date changed from 1 May 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Additional trial centre added as reported by ClinicalTrials.gov, last updated 19 Feb 2009.
    • 19 Feb 2009 Trial phase changed from II to I/II as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top